Advances in oncology continue to redefine how cancer is understood and treated, and the 2nd Edition of the International Cancer and Precision Oncology Conference (ICPOC 2026) stands as a global platform reflecting this progress. Scheduled for November 23-25, 2026, the Cancer Conference will take place in Singapore, while also offering hybrid participation options, enabling engagement beyond geographical boundaries.
ICPOC 2026 is designed to bring together oncologists, cancer researchers, genomic scientists, clinicians, pharmaceutical experts, and healthcare innovators committed to advancing precision-driven cancer care. The Upcoming Oncology Conferences program explores molecular oncology, biomarker discovery, targeted therapies, immuno-oncology, clinical genomics, and personalized treatment pathways across multiple cancer types.
A key emphasis of Precision Oncology Conference is the translation of laboratory discoveries into real-world clinical applications. Scientific discussions will cover emerging diagnostic tools, data-driven oncology strategies, AI-assisted decision-making, and novel therapeutic combinations. Participants will gain insight into evolving cancer treatment models that prioritize patient-specific outcomes.
The event supports virtual access, allowing registered participants to join scientific sessions, keynote addresses, and expert-led discussions through a digital conference platform. This flexible format ensures global inclusivity while maintaining academic rigor and professional interaction.
With contributions from internationally recognized speakers and industry leaders, ICPOC 2026 encourages cross-disciplinary dialogue and collaboration. Whether attending onsite in Singapore or through an online conference format, participants will benefit from evidence-based knowledge, innovative perspectives, and global networking opportunities.
ICPOC 2026 serves as a valuable knowledge-sharing forum for professionals shaping the future of oncology and precision medicine, reinforcing its role as a leading international cancer conference in 2026.